Effectiveness Versus Efficacy: The Limited Value in Clinical Practice of High Dose Dexamethasone Suppression Testing in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing's Syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1780-1785

  Aron, David C ^a,c   Raff, Hershel ^b   Findling, James W ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; ECTOPIC CORTICOTROPIN PRODUCTION; EVALUATION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; THEORETICAL MODEL;

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; ADULT; CUSHING SYNDROME; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0031154338     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.6.3991     Document Type: Article

References (29)

1. Findling JW, Doppman JL. 1994 Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 23:511-538.
2. Kaye TB, Crapo L. 1990 The Cushing syndrome: an update on diagnostic tests. Ann Intern Med. 112:434-444.
3. Orth DN. 1995 Cushing's syndrome. N Engl J Med. 332:791-803.
4. Orth DN. 1994 The Cushing syndrome: quest for the holy grail. Ann Intern Med. 121:377-378.
5. Liddle GW. 1960 Tests of pituitary-adrenal suppressibililty in the diagnosis of Cushing's syndrome. J Clin Endocrinol. 20:1539.
6. Crapo L. 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism. 9:955-977.
7. Bruno OD, Rossi MA, Contreras LN, et al. 1985 Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh). 109:158-162.
8. Tyrrell JB, Findling JW, Aron DC, et al. 1986 An overnight high dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 104:180-186.
9. Grossman AB, Howlett TA, Perry L, et al. 1988 CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf). 29:167-178.
10. Hermus AR, Pesman GJ, Benraad T, Pieters GF, Smals AG, Kloppenborg PW. 1986 The corticotropin-releasing hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Lancet. 2:540-544.
11. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler Jr GB. 1994 A comparison of the standard high dose dexamethasone suppression test, and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 78:418-422.
12. Flack MR, Oldfield EH, Cutler Jr GB, et al. 1992 Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of Cushing syndrome. Ann Intern Med. 116:211-217.
13. Findling JW, Kehoe ME, Shaker JL, Raff H. 1991 Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropic (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab. 73:408-413.
14. Tyrrell JB, Wilson CB. 1994 Cushing's disease, therapy of pituitary adenomas. Endocrinol Metab Clin North Am. 23:925-938.
15. Raff H, Findling JW. 1989 A new immunoradiometric assay for corticotropin evaluated in normal subjects, and patients with Cushing's syndrome. Clin Chem. 35:596-600.
16. Hanley JA, McNeil BJ. 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:29-36.
17. Centor RM, Schwartz JS. 1985 An evaluation of methods for estimating the area under the receiver operating characteristic (ROC) curve. Med Decision Making. 5:149-156.
18. Hilden J. 1991 The area under the ROC curve and its competitors. Med Decision Making. 11:95-101.
19. Ash A, Schwartz M. Evaluating the performance of risk adjustment methods: dichotomous measures. In: lezzoni LI, ed. Risk adjustment for measuring health outcomes 1994. Ann Arbor: Health Administration Press; 313-346.
20. Centor RM. 1985 A Visicalc program for estimating the area under receiver operating characteristic (ROC) curve. Med Decision Making. 5:139-148.
21. Savitz DA, Olshan AF. 1995 Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 142:904-908.
22. Poses RM, Cebul RD, Collins M, Fager SS. 1986 The importance of disease prevalence in transporting clinical prediction rules. Ann Intern Med. 105:586-591.
23. Dwyer AJ, Frank JA, Doppman JL, et al. 1987 Pituitary adenomas in patients with Cushing's disease: initial experience with Gd-DTPA enhanced MR imaging. Radiology 63:421.
24. Escourolle H, Abecassis JP, Bertagna X, et al. 1993 Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol (Oxf). 39:307-313.
25. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. 1994 Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 120:817-820.
26. Wasson JH, Sox HC, Neff RK, Goldman L. 1985 Clinical prediction rules. Applications and methodological standards. N Engl J Med. 313:793-799.
27. Allison JJ, Centor RM. 1996 Why models predicting bacteremia in general medical patients do not work. J Gen Intern Med. 11:132-134.
28. Braitman LE, Davidoff F. 1996 Predicting clinical states in individual patients. Ann Intern Med. 125:406-412.
29. Flagle CD. 1973 The value of information for decision making. In: Yaffee R, Zalkind D, eds. Evaluation in health services delivery: proceedings of an Engineering Foundation conference. New York: Engineering Foundation; 55-61.